Appendix 4E and Preliminary Financial Report

Cleo Diagnostics Ltd (‘COV’) is pleased to present its Preliminary Financial Report for the year ended 30 June 2023.

Click here for the full ASX Release

This article includes content from CLEO Diagnostics, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.